Epigenetics Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025 - Garner Insights
  • Home >>
  • Pharmaceuticals and Healthcare >>
  • Epigenetics Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Epigenetics Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240207 Report 21st May, 2018 Region : Global Pages Reports Monitor

Epigenetics Market by Product (Kits, Bioinformatics Tools), by Application (Oncology, Developmental Biology), By Technology (DNA Methylation, Histone Modification), By End-User (Pharmaceutical & Biotechnological Companies) Global Forecast till 2025


Market Synopsis

Epigenetics is a phenomenon refers to the study of chemical modification of particular genes or genes associated with proteins of an organism. These heritable changes in the genome occur without altering the DNA or genetic code. Epigenetics is a continuation of genetics and developmental biology that comes in context of cellular and physiological peculiarity variations provoked by external or environmental stimuli. It has the ability to influence DNA transcription and translation and changes the gene function without any mutation. This leads to changes in phenotype, with the genotype of the organism being constant. Histone modification and DNA methylation are the great examples of epigenetic processes wherein transformation in gene expression is seen without the changes in DNA sequence. Epigenetic modifications are contributed by different factors such as surrounding environment, age, disease state, lifestyle and many others. 


Increasing prevalence of various types of cancer across the globe is the prime factor responsible to drive the growth of the epigenetics market. According to the National Cancer Institute under the U.S. Department of Health and Human Services, the number of new cancer cases per year is expected to rise to 23.6 million by 2030. Increase funding, intensified research and developmental programmes and growing usage of epigenetics in non-oncology diseases further boosts the growth of the market. Several organizations such as NCI, IHEC, NIH and EGRP facilitate funding and support R&D, product development practices pertaining to the field of epigenetics acts in favour or the market.


In addition, surge in partnership among pharamaceutical, biotech companies, academies and institutes propel the growth of the epigenetic market. However, dearth of skilled professionals and huge cost of instruments may act as deterrent to expansion of the market. Growing application of epigenetics in personalized medicine and targeted therapy incorporates significant opportunities for further development of the market.


Segmentation

The global epigenetics market is segmented on the basis of product, application, technology, end-user and region.


Based on product the market is broadly segmented into kits, reagents, enzymes, instruments and consumables and bioinformatics tools. 


Application wise market is separated into oncology, developmental biology, metabolic diseases, cardiovascular diseases, and immunology.


Depending upon technology, the market is divided into DNA methylation, histone modification.

In terms of end-user the market is categorized into academic & research institutes, pharmaceutical & biotechnological companies and contract research organizations. 


Regional Analysis

The global epigenetics market geographically is segmented into Asia-Pacific, North America, Europe and LAMEA. Rising incidences of various diseases, increased R&D expenditure, rise in epigenetics research activities, suitable administrative auxiliary exercises and existence of key players drives the growth of epigenetics market in the North America. Asia-Pacific exhibits substantial potential for the expansion of epigenetics market due to surge in healthcare expenses, high prevalence of cancer and untapped potential emerging market such as India and China with huge population base.  According to India Against Cancer organization it has been estimated that near about 2.5 million people are living with cancer whereas more than 7 lakh new cancer patients are registered every year. The growth of the market in LAMEA is slow owing to poverty, less availability of funding, low awareness and undeveloped healthcare, pharma and biotechnological sectors. 


Key players

The prominent market players running in the market are Sigma-Aldrich Corporation, QIAGEN N.V Thermo Fisher Scientific, Inc., Novartis AG, Abcam Plc., Merck & Co., New England Biolabs, Inc., Illumina, Epizyme Inc. and Active Motif.


Global Epigenetics Market Segmentation

• By Product

o Kits

o Reagents

o Enzymes

o Instruments & Consumables

o Bioinformatics Tools

• By Application 

o Oncology

o Developmental Biology

o Metabolic Diseases

o Cardiovascular Diseases

o Immunology

• By Technology

o DNA Methylation

o Histone Modification

• By End-User

o Academic & Research Institutes

o Pharmaceutical & Biotechnological Companies

o Contract Research Organizations

• By Geography

o North America

 U.S.

 Canada

 Mexico

o Europe

 UK

 Germany

 France

 Italy

 Spain

 Rest of Europe

o Asia-Pacific

 China

 India

 Japan

 South Korea

 Rest of Asia-Pacific

o LAMEA

 Brazil

 Saudi Arabia

 South Africa

 Rest of LAMEA 

• Key Market Players

o Sigma-Aldrich Corporation

o QIAGEN N.V

o Thermo Fisher Scientific, Inc.

o Novartis AG

o Abcam Plc.

o Merck & Co.

o New England Biolabs, Inc.

o Illumina

o Epizyme Inc.

o Active Motif

Research Scope


 

The study for Global Epigenetics Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales.

 

Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 


The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market.  


1. Introduction

1.1. Market Definition

1.2. Market Scope

2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions

3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 

4. Product Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Kits

4.2.2. Reagents

4.2.3. Enzymes

4.2.4. Instruments & Consumables

4.2.5. Bioinformatics Tools

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

5. Application Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Oncology

5.2.2. Developmental Biology

5.2.3. Metabolic Diseases

5.2.4. Cardiovascular Diseases

5.2.5. Immunology

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

6. Technology Overview

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025

6.2.1. DNA Methylation

6.2.2. Histone Modification

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

7. Application Overview

7.1. Introduction

7.2. Market Size & Forecast, 2015 to 2025

7.2.1. Academic & Research Institutes

7.2.2. Pharmaceutical & Biotechnological Companies

7.2.3. Contract Research Organizations

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

8. Regional Overview

8.1. Introduction

8.2. Market Size & Forecast, 2015 to 2025

8.2.1. North America

8.2.1.1. U.S.

8.2.1.2. Canada

8.2.1.3. Mexico

8.2.2. Europe

8.2.2.1. UK

8.2.2.2. Germany

8.2.2.3. France

8.2.2.4. Italy 

8.2.2.5. Spain

8.2.2.6. Turkey

8.2.2.7. Rest of Europe

8.2.3. Asia-Pacific

8.2.3.1. China

8.2.3.2. India

8.2.3.3. Japan

8.2.3.4. South Korea

8.2.3.5. Rest of Asia-Pacific

8.2.4. LAMEA

8.2.4.1. Brazil

8.2.4.2. Saudi Arabia

8.2.4.3. South Africa

8.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

9. Manufacturer/ Vendor Profile

9.1. The following attributes will be considered while profiling key manufacturers in this industry: 

9.1.1. Company Overview

9.1.2. Financial Synopsis

9.1.3. Recent Developments

9.1.4. R&D Investments (if any)

9.1.5. Strategy Overview (Analyst Perspective)

9.1.6. Product Portfolio

9.2. Companies Profiled

9.2.1. Sigma-Aldrich Corporation

9.2.2. QIAGEN N.V

9.2.3. Thermo Fisher Scientific, Inc.

9.2.4. Novartis AG

9.2.5. Abcam Plc.

9.2.6. Merck & Co.

9.2.7. New England Biolabs, Inc.

9.2.8. Illumina

9.2.9. Epizyme Inc.

9.2.10. Active Motif

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: sales@garnerinsights.com